The success of Viagra initially fueled a surge for pharma, nevertheless recent changes present a complicated scenario for shareholders. Off-patent alternatives are eroding revenue, and persistent legal battles add more https://joycekrmz535369.qodsblog.com/41344277/the-blue-pill-and-pharma-a-volatile-investment